Since the early part of the last decade, the prostate cancer literature has been rife with articles purporting the utility of minimally invasive surgery for the performance of radical prostatectomy. There have been opponents citing lack of tactile feedback, an increased incidence of the need for salvage therapy and an increased complication rate, especially in the early literature comparing open and laparoscopic techniques. Some even argued that there is no difference in terms of length of hospital stay and return to normal activity, a finding which may be achievable at some centers but one which seems intuitively unlikely when broadly applied considering the findings for any other type of minimally invasive procedure. Some would also suggest that the additional costs are not justified. Conversely, the advocates would argue that the better visualization in a less bloody field has resulted in the exact opposite findings with decreased complication rates, decreased use of salvage therapy and decreased hospital stay.
Since the early part of the last decade, the prostate cancer literature has been rife with articles purporting the utility of minimally invasive surgery for the performance of radical prostatectomy. There have been opponents citing lack of tactile feedback, an increased incidence of the need for salvage therapy and an increased complication rate, especially in the early literature comparing open and laparoscopic techniques. Some even argued that there is no difference in terms of length of hospital stay and return to normal activity, a finding which may be achievable at some centers but one which seems intuitively unlikely when broadly applied considering the findings for any other type of minimally invasive procedure. Some would also suggest that the additional costs are not justified. Conversely, the advocates would argue that the better visualization in a less bloody field has resulted in the exact opposite findings with decreased complication rates, decreased use of salvage therapy and decreased hospital stay. Premier hospital database, and found that 90-day complication rates were 32% less likely with robotic prostatectomy and transfusions were 66% less likely. 3 They were also able to shed light on the issue of additional expense. These authors found that while robotic prostatectomy was associated with an additional expense of $4,528 for the 90-day period, the highest volume surgeons had an additional expense of only $1,990. In their view the small incremental cost, especially in the hands of high volume surgeons, is justified by the reduction in morbidity for the patient.
From my standpoint, as someone who has substantial surgical experience with both techniques, robotic prostatectomy has superior or at least equal oncologic efficacy and complication rates compared to open prostatectomy and in 2016 any small incremental expense justifies its use. I believe the most current literature supports that view and this debate should finally be put to rest.
